P. Das

发表

International consensus guidelines on Clinical Target Volume delineation in rectal cancer.

Karin Haustermans, Vincenzo Valentini, Claudio Coco, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Karin Haustermans, Vincenzo Valentini, Felipe A Calvo, 2010, The Lancet. Oncology.

Quality indicators in radiation oncology.

J. Albert, P. Das, P. Das, 2013, International journal of radiation oncology, biology, physics.

Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.

Gabriel O Sawakuchi, Yelin Suh, Sam Beddar, 2016, International journal of radiation oncology, biology, physics.

ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.

R. Advani, J. Friedberg, C. Flowers, 2010, Current problems in cancer.

Chapter 24 – The Colon and Rectum

N. Janjan, P. Das, S. Krishnan, 2010 .

Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

Quan P. Ly, M. Orringer, M. Washington, 2016 .

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, J. Ajani, J. Lacy, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Multi-organ segmentation of abdominal structures from non-contrast and contrast enhanced CT images

Skylar S. Gay, Callistus M. Nguyen, E. Holliday, 2022, Scientific Reports.

Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials.

Charles R. Thomas, R. Jagsi, C. Fuller, 2021, Mayo Clinic proceedings.

Radiation-Induced Liver Disease and Modern Radiotherapy.

E. Koay, P. Das, D. Owen, 2018, Seminars in radiation oncology.

Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States

T. Buchholz, J. Huo, P. Das, 2013, Cancer.

Metformin use and improved response to therapy in rectal cancer

J. Skibber, C. Garrett, P. Kelly, 2013, Cancer medicine.

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, M. Orringer, M. Washington, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

Issam El Naqa, Prajnan Das, Aditya Apte, 2009, International journal of radiation oncology, biology, physics.

Phase II trial of neoadjuvant bevacizumab (BEV), capecitabine (CAP), and radiotherapy (XRT) for locally advanced rectal cancer

L. Ellis, J. Skibber, B. Feig, 2008 .

Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.

E. Lin, J. Skibber, B. Feig, 2006, International journal of radiation oncology, biology, physics.

Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

Jeffrey S. Morris, S. Hamilton, E. Lin, 2006, International journal of radiation oncology, biology, physics.

Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer

J. Skibber, B. Feig, R. Wolff, 2007, Cancer.

Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.

A. Koong, J. Herman, E. Koay, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer

C. N. Coleman, B. Vikram, D. Raben, 2019, Cancer.

Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial.

J. Skibber, I. Shureiqi, S. Kopetz, 2014, International journal of radiation oncology, biology, physics.

Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma

J. Ajani, N. Ikoma, Y. Chiang, 2023, Cancers.

Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer

L. Ellis, L. Levy, J. Skibber, 2006, American journal of clinical oncology.

Novel Radiotherapy Technologies in the Treatment of Gastrointestinal Malignancies.

E. Holliday, J. Herman, P. Das, 2020, Hematology/oncology clinics of North America.

Do We Need Intensity-Modulated Radiation Therapy (IMRT) Routinely in the Preoperative Setting for Rectal Cancer?

P. Das, C. Crane, J. Cox, 2012, Current Colorectal Cancer Reports.

Number of lymph nodes examined and prognosis among pathologically lymph node‐negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma

J. Skibber, B. Feig, P. Das, 2011, Cancer.

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

Charles R. Thomas, C. Fuller, B. Minsky, 2020, Cancers.

A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer

K. Spindler, E. Deutsch, P. Franco, 2022, Cancers.

Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States

S. Cantor, S. Giordano, D. Lairson, 2015, American journal of clinical oncology.

Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia.

S. Cantor, E. Chiao, A. Deshmukh, 2014, Vaccine.

Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.

A. Rashid, R. Wolff, P. Das, 2015, The oncologist.

Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma

J. Ajani, P. Das, P. Mansfield, 2016, Annals of Surgical Oncology.

The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal

J. Vauthey, R. Wolff, P. Das, 2014, Oncotarget.

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy

J. Ajani, P. Das, B. Badgwell, 2017, Journal of Hematology & Oncology.

Gastric Cancer, Version 2.2013

M. Orringer, M. Washington, J. Ajani, 2013 .

Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer

J. Ajani, B. Minsky, P. Das, 2020, Journal of gastric cancer.

Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved

J. Ajani, W. Hofstetter, B. Minsky, 2018, Annals of Surgical Oncology.

Tumor regression grade in gastric cancer after preoperative therapy.

J. Ajani, B. Minsky, K. Fournier, 2019, Journal of Clinical Oncology.

Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma

J. Ajani, B. Minsky, P. Das, 2020, Annals of Surgical Oncology.

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer

E. Holliday, J. Ajani, C. Taniguchi, 2019, Advances in radiation oncology.

Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance

J. Ajani, R. Slack, Jeffrey H. Lee, 2017, Oncotarget.

ACR Appropriateness Criteria® Resectable Stomach Cancer.

T. Pawlik, A. Koong, K. Goodman, 2015, Oncology.

Medical management of gastric cancer: a 2014 update.

J. Ajani, P. Das, M. Blum, 2014, World journal of gastroenterology.

Adjuvant and neoadjuvant therapy for gastric cancer: taking stock of the options.

J. Ajani, P. Das, V. Strong, 2012, Gastrointestinal cancer research : GCR.

Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience

J. Ajani, Jeffrey H. Lee, M. Bhutani, 2012, Oncology.

Gastrointestinal

E. Holliday, P. Das, P. Das, 2021, Proton Therapy.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Esophageal and Esophagogastric Junction Cancers, Version 2.2019

J. Ajani, C. Willett, D. Bentrem, 2019 .

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

M. Orringer, M. Washington, J. Ajani, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Gastric cancer.

M. Orringer, M. Washington, J. Ajani, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Potentially curable gastric adenocarcinoma treated without surgery.

J. Ajani, Jeffrey H. Lee, M. Bhutani, 2018, European journal of cancer.

Clinical benefit of palliative radiation therapy in advanced gastric cancer

J. Ajani, N. Janjan, P. Das, 2008, Acta oncologica.

Prognostic factors for squamous cell cancer of the anal canal.

J. Ajani, P. Das, C. Crane, 2008, Gastrointestinal cancer research : GCR.

Esophageal and esophagogastric junction cancers.

Quan P. Ly, Christopher Willett, Rajesh N Keswani, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells

J. Ajani, Jeffrey H. Lee, M. Bhutani, 2020, Surgery Today.

The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation

J. Ajani, Jeffrey H. Lee, M. Bhutani, 2016, Oncology.

Esophageal and esophagogastric junction cancers, version 1.2015.

M. Orringer, M. Washington, J. Ajani, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer

E. Holliday, C. Taniguchi, A. Koong, 2023, Cancers.

Performance Status Restriction in Phase III Cancer Clinical Trials.

Charles R. Thomas, R. Jagsi, Benjamin D. Smith, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively

J. Ajani, Jeffrey H. Lee, M. Bhutani, 2015, Oncology.

Impact of PET/CT-Based Radiation Therapy Planning in Gastrointestinal Malignancies.

P. Das, C. J. Tsai, P. Das, 2011, PET clinics.

Esophageal and Esophagogastric Junction Cancers Clinical Practice Guidelines in Oncology

M. Orringer, M. Washington, J. Ajani, 2011 .

Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.

P. Thall, M. Bhutani, E. Koay, 2023, The Lancet Oncology.

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer

E. Holliday, C. Taniguchi, A. Koong, 2023, Cancers.

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer

E. Holliday, C. Taniguchi, A. Koong, 2022, Clinical and translational radiation oncology.

Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network

E. Holliday, C. Taniguchi, A. Koong, 2021, Clinical and translational radiation oncology.

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer

E. Holliday, C. Taniguchi, A. Koong, 2020, Advances in radiation oncology.

Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer.

T. Briere, P. Kelly, P. Das, 2011, International journal of radiation oncology, biology, physics.

Diagnosis and Definition of Locally Advanced and Borderline Pancreas Cancer

T. Pawlik, R. Abrams, A. Koong, 2017 .

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

E. Holliday, C. Taniguchi, A. Koong, 2021, Advances in Radiation Oncology.

Dose escalation for locally advanced pancreatic cancer: How high can we go?

E. Holliday, C. Taniguchi, A. Koong, 2018, bioRxiv.

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy

E. Holliday, A. Maitra, C. Taniguchi, 2018, Cancer.

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

Douglas B. Evans, R. Wolff, G. Varadhachary, 2007, Cancer.

ACR Appropriateness Criteria® Resectable Pancreatic Cancer.

T. Pawlik, R. Abrams, A. Koong, 2017, American journal of clinical oncology.

Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.

L. Ellis, S. Hamilton, J. Skibber, 2010, International journal of radiation oncology, biology, physics.

Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma

J. Ajani, L. Ho, P. Das, 2017, Annals of Surgical Oncology.

A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology

J. Ajani, B. Minsky, P. Das, 2020, Annals of Surgical Oncology.

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, J. Ajani, J. Lacy, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

ACR Appropriateness Criteria® Resectable Rectal Cancer

A. Koong, K. Goodman, W. Suh, 2012, Radiation Oncology.

Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer

Jeffrey E. Lee, A. Maitra, P. Bhosale, 2019, JCO precision oncology.

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

Jeffrey E. Lee, Douglas B. Evans, A. Maitra, 2016, Journal of Gastrointestinal Surgery.

Adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma: Retrospective cohort analysis.

F. Deniz, R. Vassilopoulou-sellin, S. Waguespack, 2012 .

A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma.

Jeffrey E. Lee, F. Deniz, P. Das, 2013, The Journal of clinical endocrinology and metabolism.

Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer

R. Wolff, M. Katz, J. Fleming, 2015, Acta oncologica.

Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications.

A. Darzi, A. Mirnezami, P. Das, 2013, Surgical oncology.

Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.

Charles R. Thomas, A. Raldow, E. Ruíz-García, 2020, Practical radiation oncology.

Utility of FNAC in salivary gland swellings with clinico-histological correlation in a tertiary care hospital

P. Das, N. Pandey, K. Dash, 2020, IP Journal of Diagnostic Pathology and Oncology.

Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

Sunil Krishnan, Prajnan Das, Christopher H Crane, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Executive Summary of the ARS Appropriate Use Criteria for Local Excision in Rectal Cancer.

K. Goodman, W. Suh, J. Herman, 2019, International journal of radiation oncology, biology, physics.

A Twenty-Year Experience with Adenocarcinoma of the Anal Canal

R. Gonzalez, J. Skibber, P. Das, 2009, Diseases of the colon and rectum.

Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome.

P Das, A. Ng, B. Silver, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumors.

J. Vauthey, P. Das, S. Krishnan, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.

Douglas B. Evans, R. Wolff, P. Pisters, 2008, International journal of radiation oncology, biology, physics.

Executive Summary of the ARS Appropriate Use Criteria for Treatment of Anal Cancer.

Nancy A. Bianchi, K. Goodman, W. Suh, 2019, International journal of radiation oncology, biology, physics.

Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.

Jagpreet Chhatwal, Prajnan Das, Scott B Cantor, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

ARS Appropriate Use Criteria ANAL CANCER EXPERT PANEL ON ANAL CANCER:

Timothy, Nancy A. Bianchi, K. Goodman, 2019 .

Combined modality therapy of localized gastric and esophageal cancers.

J. Ajani, N. Fukami, P. Das, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Gastric Cancer, Version 2.2022

Quan P. Ly, J. Ajani, J. Lacy, 2022 .

Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis.

G. Varadhachary, P. Kelly, P. Das, 2012, International journal of radiation oncology, biology, physics.

Vertebral Metastases and Spinal Cord Compression

D. Kuban, E. Lin, N. Janjan, 2009 .

Improving efficiency and reducing costs of MRI-Guided prostate brachytherapy using Time-Driven Activity-Based costing.

D. Kuban, T. Bathala, R. Kudchadker, 2021, Brachytherapy.

Clinical Impact of Positive Surgical Margins in Gastric Adenocarcinoma in the Era of Preoperative Therapy

J. Ajani, B. Minsky, P. Das, 2023, Annals of Surgical Oncology.

Shifting sands: the role of radiotherapy for patients with gastric and gastroesophageal adenocarcinoma.

P. Das, E. Ludmir, P. Das, 2021, Translational gastroenterology and hepatology.

Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma

J. Ajani, J. Fleming, B. Minsky, 2021, Annals of surgery.

Determinants of Survival for Patients with Neoadjuvant-Treated Node-Negative Gastric Cancer

J. Ajani, B. Minsky, P. Das, 2021, Annals of Surgical Oncology.

Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival

J. Ajani, B. Minsky, P. Das, 2021, Journal of surgical oncology.

Tumor Regression Grade in Gastric Cancer After Preoperative Therapy

J. Ajani, B. Minsky, P. Das, 2020, Journal of Gastrointestinal Surgery.

Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma

J. Ajani, Jeffrey H. Lee, M. Bhutani, 2020, Oncology.

Molecular biomarkers in gastric cancer.

J. Ajani, P. Das, A. Matamoros, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Esophageal cancer: Is preoperative chemoradiation the new standard?

P. Das, 2010, Journal of gastrointestinal oncology.

Multimodality approaches to localized gastric cancer.

J. Ajani, Jeffrey H. Lee, M. Bhutani, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Gastric and gastro-oesophageal cancer therapy

J. Ajani, P. Das, P. Das, 2005, Expert opinion on pharmacotherapy.

Clinical Investigation : Gastrointestinal Cancer Intensity-Modulated Radiation Therapy With Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma

J. Ajani, A. Beddar, T. Briere, 2012 .

Patient-Reported Sexual Function, Bladder Function and Quality of Life for Patients with Low Rectal Cancers with or without a Permanent Ostomy

E. Holliday, A. Koong, E. Koay, 2023, Cancers.

Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Practical radiation oncology.

Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.

P. Bhosale, H. Thames, T. Hong, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.

J. Ajani, P. Bhosale, J. Skibber, 2007, International journal of radiation oncology, biology, physics.

Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone

S. Curley, Douglas B. Evans, I. Wistuba, 2008, Annals of Surgical Oncology.

Navigating Nodal Metrics for Node-Positive Gastric Cancer in the United States: An NCDB-Based Study and Validation of AJCC Guidelines.

J. Ajani, B. Minsky, P. Das, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Gastric cancer: apples will always be apples.

J. Ajani, P. Das, K. Fournier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis

J. Skibber, S. Kopetz, D. Weksberg, 2017, Advances in radiation oncology.

Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma.

E. Holliday, C. Taniguchi, J. Skibber, 2017, Journal of gastrointestinal oncology.

Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection.

E. Holliday, C. Taniguchi, A. Koong, 2023, Clinical colorectal cancer.

Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten‐year institutional experience

J. Skibber, B. Feig, P. Das, 2014, Journal of surgical oncology.

The ypT category does not impact overall survival in node negative gastric cancer

J. Ajani, W. Hofstetter, B. Minsky, 2018, Journal of surgical oncology.

Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006–2014 using propensity score matching

J. Ajani, C. Roland, W. Hofstetter, 2018, Gastric Cancer.

Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006‐2014

Xianglin L. Du, J. Ajani, C. Roland, 2018, Cancer.

Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer.

J. Ajani, B. Minsky, P. Das, 2017, International journal of radiation oncology, biology, physics.

Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.

J. Ajani, P. Das, K. Fournier, 2015, Journal of the American College of Surgeons.

Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy

J. Ajani, W. Hofstetter, P. Das, 2017, Gastric Cancer.

Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer

J. Ajani, B. Minsky, P. Das, 2020, Journal of surgical oncology.

Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases

J. Ajani, S. Swisher, W. Hofstetter, 2020, Gastric Cancer.

Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy

J. Ajani, B. Minsky, P. Das, 2019, Annals of Surgical Oncology.

A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer

J. Skibber, M. Munsell, S. Guha, 2022, Journal of gastrointestinal oncology.

Neoadjuvant Chemoradiation with Capecitabine Versus Infusional 5-fluorouracil (5-FU) for Locally Advanced Rectal Cancer: A Matched Pair Analysis

E. Lin, J. Skibber, B. Feig, 2005 .

The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials.

C. Taniguchi, A. Koong, C. Rödel, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer

J. Skibber, S. Kopetz, B. Feig, 2010, Annals of Surgical Oncology.